Preventing cancer and reducing cancer morbidity and mortality are the unifying long-range goals of the Cancer Control and Population Sciences (CCPS) Program. This Program's shared vision is to generate outstanding science that improves cancer prevention and care through bold discovery and applications. Investigative work is within two broad areas: cancer genetics and epidemiology and behavioral and outcomes research. Research in both thematic areas aims at identifying efficient intervention targets and effective intervention techniques, including individualized and patient-centric approaches along the cancer control continuum. The following are key areas of programmatic strength and depth: ? Genetic risk prediction and gene localization/discovery ? The study of gene-environment interactions ? Development and testing of models for translation of discoveries into interventions, with the goal of assuring quality implementation and broad access The CCPS Program has made considerable progress in addressing its scientific and programmatic goals during the previous five years. Recent major scientific discoveries include 1) localization and discovery of predisposing genes for prostate cancer and melanoma, 2) seminal work on the role of gene-environment interactions involving inflammatory and metabolic pathways in breast and colorectal cancer etiology, and 3) characterization of behavioral and psychosocial outcomes of genetic risk communication interventions for hereditary breast and ovarian cancer and for melanoma. Led by Anita Kinney, PhD, RN, the CCPS Program includes 32 members from five schools/colleges and 12 departments. Between July 2003 and March 2009, this highly productive and collaborative group generated 443 cancer-relevant publications, of which 25% were intra- and 20% were inter-programmatic collaborations. Program direct cost peer-reviewed funding in 2008 was $11M, including $7.3M in NCI funding. The synergistic relationship between the Cancer Center and the CCPS Program is highly beneficial to both groups. CCPS members provide methodological expertise in both basic and applied research and participate in translational research activities that bridge basic discoveries with clinical and population applications. The Cancer Center provides appropriate supportive funding, access to Shared Resources and other Center facilities, facilitation of transdisciplinary collaborations, and funding for faculty recruitments. Over the next five years, CCPS anticipates facilitating more individualized approaches to cancer prevention and treatment through relevant research findings. In addition, CCPS foresees its research in prevention and control will lead to new discoveries aimed at reducing cancer disparities among underserved populations, including American Indian, Hispanic/Latino, elderiy, and rural peoples.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Utah
Salt Lake City
United States
Zip Code
Albright, Frederick; Stephenson, Robert A; Agarwal, Neeraj et al. (2015) Prostate cancer risk prediction based on complete prostate cancer family history. Prostate 75:390-8
Eiring, A M; Page, B D G; Kraft, I L et al. (2015) Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia. Leukemia 29:586-97
Lerman, Daniel M; Monument, Michael J; McIlvaine, Elizabeth et al. (2015) Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology Group. Pediatr Blood Cancer 62:759-65
Quackenbush, John F; Cassidy, Pamela B; Pfeffer, Lawrence M et al. (2014) Isolation of circulating microRNAs from microvesicles found in human plasma. Methods Mol Biol 1102:641-53
Clark, Kathleen A; Graves, Barbara J (2014) Dual views of SRF: a genomic exposure. Genes Dev 28:926-8
Zhang, Rui; Yang, Jiyuan; Sima, Monika et al. (2014) Sequential combination therapy of ovarian cancer with degradable N-(2-hydroxypropyl)methacrylamide copolymer paclitaxel and gemcitabine conjugates. Proc Natl Acad Sci U S A 111:12181-6
Oakley, Gretchen M; Curtin, Karen; Layfield, Lester et al. (2014) Increased melanoma risk in individuals with papillary thyroid carcinoma. JAMA Otolaryngol Head Neck Surg 140:423-7
Van Vranken, Jonathan G; Bricker, Daniel K; Dephoure, Noah et al. (2014) SDHAF4 promotes mitochondrial succinate dehydrogenase activity and prevents neurodegeneration. Cell Metab 20:241-52
Smith, M A; Hoffman, L M; Beckerle, M C (2014) LIM proteins in actin cytoskeleton mechanoresponse. Trends Cell Biol 24:575-83
Monument, Michael J; Johnson, Kirsten M; McIlvaine, Elizabeth et al. (2014) Clinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma: a report from the Children's Oncology Group. PLoS One 9:e104378

Showing the most recent 10 out of 805 publications